Mar 02,2022

Massachusetts General Hospital to Co-Develop VR Digital Therapeutic for Stem Cell Patients

Massachusetts General Hospital ("MGH") announced a research agreement with Rocket VR Health, an emerging digital therapeutics company developing clinically validated virtual reality therapies that enhance the quality of life of cancer patients, their families and their caregivers. The research will study the effects of daily Virtual Reality Therapy's effect on patients during their entire hospital stay. As part of the agreement, Rocket VR Health will leverage its virtual reality therapy platform to co-develop a VR digital therapeutic solution based on population-specific well-researched care interventions created by Massachusetts General Hospital.

COLLABORATION PARTNERSHIP

#r&d

#virtual reality

View Analyst & Ambassador Comments
Go to original news
Apr 06,2022

OxfordVR Technology a World First Success in Automating Psychological Therapy Using Virtual Reality (VR)

OxfordVR has successfully automated psychological therapy in VR for patients with mental illness. Users are guided by a virtual coach instead of a real-life therapist, allowing the treatment to reach many more patients. The technology, called gameChangeVR is a 6 week, automated, VR treatment that delivers cognitive behavioral therapy (CBT) inside safe, immersive, virtual scenarios. In the largest ever clinical trial of VR for mental health published today in The Lancet Psychiatry, gameChange was shown to help patients with schizophrenia and mood disorders with psychotic symptoms who suffer anxiety and distress in everyday situations.

PRODUCT

#cbt

#virtual reality

View Analyst & Ambassador Comments
Go to original news
Apr 19,2022

Reulay Inc Announces Results From Study That Highlights the Effects of Reulay’s Digital Video and VR Platform for the Alleviation of Anxiety, Emotional Distress, and Distraction

Reulay, a research-backed mental health platform using AI to match anxiety states to brain-based interventions, today announced data that further underscores the effectiveness of Reulay’s digital video & VR therapeutics. The purpose of this pilot study was to evaluate the safety and use of a nature-based virtual reality (VR) experience among health care providers (HCP) during a pandemic. Twenty-four frontline HCP participated in this crossover pilot where the viewing order of the experiences were randomized. The study results showed that 96% of participants felt relaxed after seeing the imagery, and with respect to anxiety (as measured by the STAI Y1), the VR "Walk in the Woods" had the greatest reduction from pre to post followed by VR "Forest of Focus"

CLINICAL STUDY

#virtual reality

View Analyst & Ambassador Comments
Go to original news
Apr 28,2022

AppliedVR and Komodo Health Partner To Validate Power of Virtual Reality As Effective Digital Therapy for Chronic Pain

Komodo Health today announced a new partnership with AppliedVR, the leader in therapeutic virtual reality (VR) for pain management. The FDA recently granted AppliedVR’s De Novo request for its flagship product, RelieVRx, and is now tapping into Komodo’s technology platform to further demonstrate the therapeutic impact of RelieVRx for patients living with chronic lower back pain. Using Komodo’s technology, AppliedVR will combine its proprietary insights with Komodo’s real-world data to conduct clinical research into the efficacy, cost savings, and health system value that RelieVRx delivers compared to traditional chronic pain treatment modalities.

COLLABORATION PARTNERSHIP

#product & service

#virtual reality

#rwe

View Analyst & Ambassador Comments
Go to original news
May 17,2022

AppliedVR Partners with Kernel to Measure Brain Activity Changes Before, During, and After Virtual Reality (VR) Treatment of Chronic Pain

AppliedVR, a pioneer in immersive digital therapeutics, and Kernel, a leader in non-invasive neuroimaging, announced a joint randomized study comparing the effect of AppliedVR’s FDA-authorized, VR-based program, RelieVRx, versus a control (VR program not designed to treat pain) on the brains of patients with chronic pain.

COLLABORATION PARTNERSHIP

#r&d

#virtual reality

View Analyst & Ambassador Comments
Go to original news
May 26,2022

Akili Integrates First-of-its-Kind Prescription Video Game Treatment with the Virtual World Through Partnership with Roblox

Akili Interactive (“Akili”), a leading digital medicine company pioneering the development of cognitive treatments through game-changing technologies, and Roblox (NYSE: RBLX), a global platform bringing millions of people together through shared experiences, today announced a collaboration that connects patients' medical treatments to their favorite virtual worlds. Initially, the companies will establish an exclusive Roblox rewards exchange tied to Akili’s EndeavorRx® treatment, and both sides are exploring additional novel approaches and opportunities to engage Akili patients through Roblox integrations.

COLLABORATION PARTNERSHIP

#product & service

#virtual reality

#pdt

View Analyst & Ambassador Comments
Go to original news
May 27,2022

Study: VR therapeutic reduces pain intensity long term, compared with sham app

The study was sponsored by AppliedVR and used its RelieVRx system, formerly known as EaseVRx, to assess its long-term effectiveness for people with chronic lower-back pain (CLBP). It followed up on earlier research that analyzed the immersive eight-week program, compared with a 2D sham experience immediately after treatment. Meanwhile, 38% of the RelieVRx cohort achieved substantial clinical meaningfulness, while only 13.2% of the sham group did.

CLINICAL STUDY

#virtual reality

View Analyst & Ambassador Comments
Go to original news
Oct 13,2022

MyndVR, Oroi partner to expand virtual reality content for seniors

American VR digital therapeutic company MyndVR and European company Oroi announced a strategic partnership to expand MyndVR's catalog of cognitive, physical and occupational therapies using Oroi content. Oroi is a VR content platform aimed at improving the wellbeing and cognitive stimulation of seniors. The company currently works in Spain, France, Germany and the U.K. With the partnership, MyndVR will offer Oroi Cognitive, which includes several exercises and games simulating daily life situations like orienting oneself within a city, shopping in a market, getting dressed and cleaning a room.

COLLABORATION PARTNERSHIP

#product & service

#virtual reality

#cbt

View Analyst & Ambassador Comments
Go to original news
Aug 26,2021

Curebase teams up with AppliedVR on pain treatment

Curebase, a platform for decentralized clinical trials, is partnering with AppliedVR to run five trials to test the effectiveness of virtual reality for treating chronic pain. The companies said the one-year partnership will focus on studying a self-administered, at-home VR therapy program. Curebase will manage patient recruitment, consent, and engagement, and collect patient-reported outcomes data.

COLLABORATION PARTNERSHIP

#r&d

#virtual reality

View Analyst & Ambassador Comments
Go to original news
Mar 22,2021

BehaVR launches VR-enabled stress management programme for clinicians

Virtual reality (VR) digital wellness company BehaVR announced Monday that it is working with healthcare organisations to introduce CenteredVR, a VR-enabled mindfulness and stress management programme, to clinicians and other workers. The company cited early data suggesting that CenteredVR, which was co-developed with Johns Hopkins University, decreased stress levels by 34% on average. According to BehaVR, the programme gradually guides users through a "soothing, immersive VR experience," helping alleviate stress through educational elements and mindfulness practices. It added that the programme, which runs on Pico Interactive's G2 4K S headsets, helps users to "optimise their stress responses, becoming less reactive and more resilient to stressors."

PRODUCT

#virtual reality

View Analyst & Ambassador Comments
Go to original news
Subscribe to VIRTUAL REALITY